Previous close | 24.76 |
Open | 22.69 |
Bid | 22.29 x 300 |
Ask | 22.46 x 700 |
Day's range | 20.19 - 23.56 |
52-week range | 20.19 - 59.61 |
Volume | |
Avg. volume | 750,783 |
Market cap | 1.083B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.66 |
Earnings date | 23 July 2024 - 29 July 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 53.13 |
Discover how AtriCure Inc achieved a 16% revenue increase and nearly 50% rise in adjusted EBITDA in the first quarter of 2024, alongside strategic product advancements.
The headline numbers for AtriCure (ATRC) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Comprehensive Analysis of AtriCure's Latest Financial Performance